PBSS 2025

InSphero at PBSS 2025

Join us at PBSS 2025  in Foster City, California. This exciting symposium will bring together experts who will discuss the latest developments in New Approach Methodologies and technologies that seek to phase out animal testing in drug development and discovery. 

Connect with us and the Pharmaceutical and Bioscience Society on Monday, October 20th, as we explore the new strategies changing the world of drug safety assessments and therapeutic innovation. 

Meet our Team at PBSS 2025

Bruno Filippi

Bruno Filippi, PhD

Vice President, Liver Safety

Sue Grepper, PhD

Director of Business Development

Scientific Talk at PBSS 2025

Primary Liver Spheroids for Drug Safety Assessment: Overview, Case Studies, and the Roadmap to FDA Qualification

Date: Monday, October 20, 2025 | 1:05 –  1:40 PM

Location: Crown Plaza Hotel, Foster City, CA 

Bruno Filippi

Bruno Filippi, PhD

Vice President, Liver Safety

PBSS 2025 Resources

3D InSight™ Liver Microtissues as Promising Pre-clinical Safety Assessment In Vitro Tools: Mechanistic Investigation of Aflatoxin B1 Toxicity in Dog, Rat and Human
An integrative in silico toolbox for derisking drug-induced liver injury (DILI) liabilities
Enabling Early Safety Assessment with Low-Input RNA-Seq in Liver Microtissues Across Species and Compound Analogs
Non-Destructive Multiplexed Imaging of 3D Liver Microtissues for Multi-Modal DILI Assessment
3D InSight™ Predictive Liver Toxicology Services
3D InSight™ Liver Microtissues Applications
Liver Microtissues – A Highly Reproducible In Vitro Test System for Safety Assessment of Small Molecules
Leveraging Human, Animal Liver Microtissues and Low-Input RNA-Sequencing to Characterize Mechanisms of Drug-Induced Liver Injury

Your Success is Our Mission - Get in Touch

Fill in form below to contact our 3D in vitro experts

Sign up for our Newsletter

Get the latest news on 3D in vitro research

Webinar registration

Fill in the form below to register

View resource

Fill in the form below to view this resource